Evaluation of efficacy and safety using Acellular Dermal Matrix as a Substitute for Middle Hepatic Vein Reconstruction During Living Donor Liver Transplantation, single-center, single-arm, prospective pilot study
Not Applicable
Recruiting
- Conditions
- Diseases of the digestive system
- Registration Number
- KCT0008243
- Lead Sponsor
- Chungnam National University Hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 10
Inclusion Criteria
1) Adults over 19 ~ 70 years old undergoing live liver transplant surgery using the right lobe of the modified liver
2) GWRW > 0.8, MELE Score < 20, Selected Patients from the Patient Group
Exclusion Criteria
1) Patients with living liver transplantation using the left lobe of the liver
2) Patients with living liver transplant using extended right lobe (when MHV reconstruction is not required)
3) If the right lobe starch section of the liver is dominant and the flow of the reconstructed middle vein is blocked, the patient's
If it is expected to have a prognosis
4) Those who cannot perform both liver CT or liver Doppler tests
5) Those who are judged unsuitable to participate in this clinical trial by other researchers
Study & Design
- Study Type
- Interventional Study
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Efficacy Evaluation Variables
- Secondary Outcome Measures
Name Time Method Stability Assessment Variables